| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 05/11/2011 | CN102050843A Method for extracting alkaloid and catechin from tea |
| 05/11/2011 | CN102050823A Synthesis and representation of guanine analogue as novel light stabilizer |
| 05/11/2011 | CN101671334B Production technology of pamabrom |
| 05/11/2011 | CN101555249B Method for synthesizing famciclovir |
| 05/11/2011 | CN101508690B Novel methods for simultaneously extracting tea polyphenol, tea polysaccharide and caffeinum from tea |
| 05/10/2011 | CA2451279C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments |
| 05/05/2011 | WO2010151737A3 Heterocyclic compounds and their uses as inhibitors of pi3 k activity |
| 05/05/2011 | WO2010110685A3 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| 05/05/2011 | US20110105749 Triazole compounds that modulate hsp90 activity |
| 05/05/2011 | US20110105508 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 05/05/2011 | US20110105434 2-amino purine derivatives and their use as anti-herpetic agents |
| 05/05/2011 | US20110105417 Drug Conjugates |
| 05/05/2011 | US20110104305 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 05/05/2011 | US20110104054 Small-Molecule HSP90 Inhibitors |
| 05/04/2011 | EP2316834A1 Thiadiazoles or oxadiazoles and their use as inhibitors of JAK protein kinase |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2011 | CN102046201A Inhibitor of analgesic tolerance |
| 05/04/2011 | CN102040610A Novel method for simultaneously extracting caffeine, tea polyphenol and tea polysaccharide from tea using mechanochemical principle |
| 05/04/2011 | CN101463033B Method for synthesizing diprophylline |
| 05/03/2011 | US7935818 Process for the preparation and purification of valgancyclovir hydrochloride |
| 04/28/2011 | WO2011049825A1 Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections |
| 04/28/2011 | US20110098295 Methods of treating anxiety, itching and psychiatric disorders |
| 04/28/2011 | US20110098294 Purine analogs |
| 04/28/2011 | US20110098248 Modulators of toll-like receptors |
| 04/28/2011 | CA2777824A1 Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections |
| 04/27/2011 | EP2313422A2 Nucleoside cyclicphosphates |
| 04/27/2011 | EP2312945A1 Purine derivatives for treatment of alzheimer's disease |
| 04/27/2011 | CN101198608B Prodrugs of A2b adenosine receptor antagonists |
| 04/26/2011 | US7932260 5-methyl-3-phenyl-2-[1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one; 3-(4-fluoro-phenyl)-5-methyl-2-[1-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ethyl]-3H-quinazolin-4-one; bone-resorption disorder or a cancer of a hematopoietic origin; disorders in which PI3K plays a role in leukocyte function |
| 04/21/2011 | WO2011046303A2 Novel method for preparing entecavir and intermediate used therein |
| 04/21/2011 | WO2008087558A3 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 04/21/2011 | US20110092491 Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase Activity |
| 04/21/2011 | US20110092458 Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases |
| 04/21/2011 | CA2777018A1 Novel method for preparing entecavir and intermediate used therein |
| 04/20/2011 | EP2311807A1 Compounds and composition as protein kinase inhibitors |
| 04/20/2011 | EP2310391A1 Pyrazine substituted purines |
| 04/20/2011 | EP2310390A1 6-(c2-6alkylseleno)purines and methods for treating neural measles viral infection therewith |
| 04/20/2011 | EP1532149B9 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 04/20/2011 | EP1517908B1 Novel benzimidazole derivatives |
| 04/20/2011 | CN1964972B Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
| 04/20/2011 | CN102026970A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 04/20/2011 | CN102020642A Preparation method of valaciclovir hydrochloride |
| 04/20/2011 | CN102020612A Method for synthesizing benzoxycarbonyl basic group |
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/14/2011 | WO2011044394A1 Purine derivatives useful as hsp90 inhibitors |
| 04/14/2011 | WO2011043491A1 Novel artificial fluorescent bases |
| 04/14/2011 | US20110086868 Specific inhibitors for vascular endothelial growth factor receptors |
| 04/14/2011 | US20110086867 6-(c2-6alkylseleno)purines and methods for treating neural measles viral infection therewith |
| 04/14/2011 | US20110086841 N-9 substituted purine compounds, compositions and methods of use |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | CA2776308A1 Purine derivatives useful as hsp90 inhibitors |
| 04/13/2011 | EP2308878A2 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and use as medicaments |
| 04/13/2011 | EP2308870A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
| 04/13/2011 | EP2308867A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
| 04/13/2011 | EP2308509A1 Inhibitor of analgesic tolerance |
| 04/13/2011 | EP2307414A2 Pi3k isoform selective inhibitors |
| 04/13/2011 | CN102015712A Heterocyclic compounds as adenosine receptor antagonist |
| 04/13/2011 | CN102015639A Compounds for use in stabilizing p53 mutants |
| 04/07/2011 | WO2011041399A2 Pi3k (delta) selective inhibitors |
| 04/07/2011 | US20110082139 Substituted 8-[6-amino-3-pyridyl]xanthines |
| 04/07/2011 | CA2775942A1 Pi3k (delta) selective inhibitors |
| 04/06/2011 | EP2305684A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 04/06/2011 | EP2305680A2 Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol |
| 04/06/2011 | EP2303884A1 Adenine receptor ligands |
| 04/06/2011 | EP2303883A1 Purine derivatives further comprising a mercapto-acylamino group as neutral endopeptidase inhibitors |
| 04/06/2011 | EP1219607B1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 04/06/2011 | CN102002044A Purine-8-ketone and thiazolopyrimidine derivatives, and preparation method and medicinal application thereof |
| 04/06/2011 | CN102002043A Method for synthesizing 6-methoxy group purine derivative in presence of 4-aminopyridine as catalyst |
| 04/06/2011 | CN101182322B Method for preparing antiviral drug of Entecavir |
| 04/05/2011 | US7919528 Antibiotic; bactericides |
| 04/05/2011 | US7919490 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/05/2011 | CA2572577C Synthesis of acyclic nucleoside derivatives |
| 03/31/2011 | WO2011035518A1 Pyrimidine derivatives and analogs, preparation method and use thereof |
| 03/31/2011 | WO2011016611A3 Adefovir dipivoxil having a novel crystal form, a production method for the same, and a composition for preventing or treating chronic hepatitis b containing the same as an active ingredient |
| 03/31/2011 | WO2010102212A3 Neurotrophin mimetics and uses thereof |
| 03/31/2011 | US20110077255 Substituted xanthine derivatives |
| 03/30/2011 | EP2301937A1 Prodrugs of A2b adenosine receptor antagonists |
| 03/30/2011 | CN101998957A Substituted xanthine derivatives |
| 03/30/2011 | CN101486681B Method for producing azathiopurine intermediate and product produced thereby |
| 03/29/2011 | US7915268 And 8-substituted 2-(imidazolo[4,5-c]pyridinyl)purines; Janus kinase 3 inhibitors; autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection |
| 03/29/2011 | CA2435730C Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 03/24/2011 | WO2010129053A3 Egfr inhibitors and methods of treating disorders |
| 03/24/2011 | WO2010110622A3 Novel crystal forms of adefovir dipivoxil and processes for preparing the same |
| 03/24/2011 | WO2010022358A8 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 03/24/2011 | US20110071142 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases |
| 03/24/2011 | US20110070192 Method of preparation of novel nucleoside analogs and uses |
| 03/23/2011 | EP2298769A1 Xanthin derivatives, their production and utilisation as medicine |
| 03/23/2011 | EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/23/2011 | CN101987851A Crystal forms of Acyclovir sodium dihydrate and preparation method thereof |
| 03/23/2011 | CN101987850A Method for preparing valganciclovir hydrochloride amorphous polymorphic substances |
| 03/23/2011 | CN101987847A Novel heterocyclic NF-kB inhibitors |
| 03/17/2011 | WO2011030798A1 8-oxodihydropurine derivative |
| 03/17/2011 | WO2010120074A3 Method for preparing crystalline adefovir dipivoxil and adefovir dipivoxil butanolate used therein |
| 03/17/2011 | US20110065738 Polycyclic guanine derivatives and use thereof |
| 03/17/2011 | CA2773848A1 Pi3 kinase inhibitors and uses thereof |
| 03/17/2011 | CA2773590A1 8-oxodihydropurine derivative |
| 03/17/2011 | CA2772907A1 Selective antibacterials for clostridium difficile infections |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295434A2 Substituted 8-heteroaryl xanthines |
| 03/16/2011 | CN101985443A Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |